932384-43-5

Basic information

• Product Name: 3-(4-Ethyl-2,2,7-trimethyl-3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-4-(2,2,2-trifluoro-ethoxy)-benzaldehyde
• Synonyms: 3-(4-Ethyl-2,2,7-trimethyl-3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-4-(2,2,2-trifluoro-ethoxy)-benzaldehyde
• CAS NO: 932384-43-5
• Molecular Weight: 421.416
• Mol File: 932384-43-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-(4-Ethyl-2,2,7-trimethyl-3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-4-(2,2,2-trifluoro-ethoxy)-benzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(4-Ethyl-2,2,7-trimethyl-3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-4-(2,2,2-trifluoro-ethoxy)-benzaldehyde(932384-43-5)
• EPA Substance Registry System: 3-(4-Ethyl-2,2,7-trimethyl-3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-4-(2,2,2-trifluoro-ethoxy)-benzaldehyde(932384-43-5)

Safety Data

• Hazardous Substances Data: 932384-43-5(Hazardous Substances Data)

Upstream product

• 932384-42-4 3-(4-Ethyl-2,2,7-trimethyl-3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-4-hydroxy-benzaldehyde 
• 79963-95-4 2,2,2-trifluoroethyl 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate 

Relevant articles and documents

Heterocyclic amide derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes

The present invention relates to compounds of Formula (I), methods for preparing these compounds, compositions, intermediates and derivatives thereof and for treating RXR mediated disorders. More particularly, the compounds of the present invention are RXR agonists useful for treating RXR mediated disorders.